Mequon, WI, United States of America

Barry M Bernstein

This inventor holds 12 USPTO granted patents and 23 published patent applications, plus 6 CIPO patents and 5 EPO patents. Top assignee: Abbvie Inc.. Active years: 2013-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barry M Bernstein. Retrieved from https://idiyas.com/inventor/barry-m-bernstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 91.7

 

 

Average Co-Inventor Count = 10.1

ph-index = 7

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 2013-2022

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: The Innovative Mind of Barry M Bernstein

Introduction

Barry M Bernstein is a remarkable inventor based in Mequon, Wisconsin, known for his significant contributions to antiviral therapies. With a total of 12 patents to his name, Bernstein has demonstrated an unwavering commitment to advancing medical science and improving patient outcomes in the field of hepatitis C treatment.

Latest Patents

Among his latest innovations, Bernstein has developed methods for treating hepatitis C virus (HCV) with interferon-free therapies. His patents propose a shorter treatment duration of no more than 12 weeks. The treatment involves administering at least two direct-acting antiviral agents to individuals infected with HCV. Notably, this regimen excludes the use of interferon or ribavirin, utilizing instead combinations of specific compounds, namely Compound 1 and Compound 2, or their pharmaceutically acceptable salts.

Career Highlights

Barry Bernstein has had a distinguished career, during which he has significantly influenced the pharmaceutical landscape. He has worked with prominent companies, including AbbVie Inc., where he played a vital role in research and development. Through his work, Bernstein has combined scientific creativity with practical applications to tackle pressing health issues.

Collaborations

Throughout his career, Bernstein has collaborated with esteemed colleagues, including Rajeev M Menon and Sven Mensing. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the innovative processes that Bernstein champions in his work.

Conclusion

Barry M Bernstein stands out as a key figure in the realm of antiviral research, with a legacy of patents that reflect his dedication to innovation. His work not only showcases his inventiveness but also highlights the importance of collaboration in the advancement of medical science. As he continues to push the boundaries of what is possible in the treatment of HCV, Bernstein's contributions will undoubtedly influence future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…